Literature DB >> 19396952

EEG stages predict treatment response in experimental status epilepticus.

Norman C Wang1, Levi B Good, Steven T Marsh, David M Treiman.   

Abstract

Progression of severity in experimental status epilepticus (SE), defined as refractoriness to first- and second-line abortive agents, may be related to a five-stage progression of electroencephalography (EEG) patterns. This was tested in the lithium-pilocarpine rat SE model. Abortive treatment with diazepam and phenobarbital was given at EEG stages I, III, and V. In stage I, the combination therapy resulted in 100% SE termination. However, stage III corresponded to high treatment resistance (0% abortion) and stage V to an intermediate response (63%). Comparisons of time-to-treatment durations showed overlap between stage I and stage III, despite having markedly different response rates to abortive medications. Therefore, EEG patterns reflect the dynamic pathophysiology of SE and can be used as reliable and specific markers to distinguish treatment-responsive from treatment-refractory SE more accurately than time alone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396952     DOI: 10.1111/j.1528-1167.2008.01911.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Electroclinical progression of subtle generalized convulsive status epilepticus: description of a case.

Authors:  José L Fernández-Torre; Eloy Rodríguez-Rodríguez; José L Vázquez-Higuera; Miguel A Hernández-Hernández
Journal:  J Neurol       Date:  2013-10-23       Impact factor: 4.849

2.  Status epilepticus: Role for etiology in determining response to benzodiazepines.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Kyle M Hawk; Stephen J Chester; Howard P Goodkin
Journal:  Ann Neurol       Date:  2018-04-10       Impact factor: 10.422

3.  Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.

Authors:  Juan M Pascual; Peiying Liu; Deng Mao; Dorothy I Kelly; Ana Hernandez; Min Sheng; Levi B Good; Qian Ma; Isaac Marin-Valencia; Xuchen Zhang; Jason Y Park; Linda S Hynan; Peter Stavinoha; Charles R Roe; Hanzhang Lu
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

4.  Electroencephalography and behavior patterns during experimental status epilepticus.

Authors:  Ewa Lewczuk; Suchitra Joshi; John Williamson; Mouna Penmetsa; Sarah Shan; Jaideep Kapur
Journal:  Epilepsia       Date:  2017-12-06       Impact factor: 5.864

5.  Somatostatin type-2 receptor activation inhibits glutamate release and prevents status epilepticus.

Authors:  Maxim Kozhemyakin; Karthik Rajasekaran; Marko S Todorovic; Samuel L Kowalski; Corinne Balint; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2013-03-05       Impact factor: 5.996

6.  Characterization of status epilepticus induced by two organophosphates in rats.

Authors:  Marko S Todorovic; Morgan L Cowan; Corrinee A Balint; Chengsan Sun; Jaideep Kapur
Journal:  Epilepsy Res       Date:  2012-05-09       Impact factor: 3.045

7.  Flupirtine and diazepam combination terminates established status epilepticus: results in three rodent models.

Authors:  Terry Zhang; Marko S Todorovic; John Williamson; Jaideep Kapur
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

8.  Transient ischemia facilitates neuronal chloride accumulation and severity of seizures.

Authors:  Thomas Blauwblomme; Volodymyr Dzhala; Kevin Staley
Journal:  Ann Clin Transl Neurol       Date:  2018-07-05       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.